BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Pearl Therapeutics Completes Phase 2b Study of Glycopyrrolate, Defines Dose-Response Curve and Identifies Optimal Dose of PT001

  September 13, 2012

   · 

  4 min read
• Genetown

  Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 20, 2012

  September 13, 2012

   · 

  1 min read
• BioForest

  Genelex Corporation Rolls Out Lifesaving DNA Healthcare System

  September 13, 2012

   · 

  2 min read
• Business

  Solta Medical, Inc. and BTL Industries Resolve Patent Dispute

  September 13, 2012

   · 

  3 min read
• Drug Development

  DUSA Pharmaceuticals Demonstrates Positive Results in Phase 2 Actinic Keratoses Extremities Study

  September 13, 2012

   · 

  1 min read
• Business

  Vical Incorporated Licenses DNA Immunization Technology and Vaxfectin® Adjuvant to Bristol-Myers Squibb Company for Use in Antibody Production

  September 13, 2012

   · 

  1 min read
• Business

  Pacific Biosciences Appoints Lucy Shapiro, Ph.D. to Board of Directors

  September 13, 2012

   · 

  1 min read
• Business

  Gentium S.p.A. Reports First Half 2012 Financial Results

  September 13, 2012

   · 

  1 min read
• Business

  REVA Medical Inc. Announces Dr. David Muller as Co-Principal Investigator for RESTORE II Clinical Trial

  September 13, 2012

   · 

  1 min read
• Drug Development

  Repros Therapeutics Inc. Provides Clinical Update for Androxal® Phase 3 Program

  September 13, 2012

   · 

  1 min read